Gregory L Weaver Atossa Therapeutics, Inc. (ATOS) insider trading activity

ATOS Quotes by TradingView

Gregory L Weaver is Former EVP, CFO, & Director of ATOSSA THERAPEUTICS, INC.. Currently has a direct ownership of 55 shares of ATOS, which is worth approximately $77. The most recent transaction as insider was on Nov 15, 2023, when has been sold 50,000 shares (Common Stock) at a price of $0.65 per share, resulting in proceeds of $32,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55
0% 3M change
99.89% 12M change
Total Value Held $77

GREGORY L WEAVER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2023
SELL
Open market or private sale
$32,500 $0.65 p/Share
50,000 Reduced 99.89%
55 Common Stock
Jun 20 2023
BUY
Open market or private purchase
$48,500 $0.97 p/Share
50,000 Added 49.97%
50,055 Common Stock
Jul 02 2021
SELL
Payment of exercise price or tax liability
$365,338 $6.4 p/Share
57,084 Reduced 34.68%
107,497 Common Stock
Jul 02 2021
SELL
Open market or private sale
$599,833 $5.58 p/Share
107,497 Reduced 100.0%
0 Common Stock
Jul 02 2021
BUY
Exercise of conversion of derivative security
$503,618 $3.06 p/Share
164,581 Added 50.0%
164,581 Common Stock

Also insider at

ATAI
ATAI Life Sciences N.V. Healthcare
Chief Financial Officer
GLW

Gregory L Weaver

Former EVP, CFO, & Director
Berlin, 2M

Track Institutional and Insider Activities on ATOS

Follow ATOSSA THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATOS shares.

Notify only if

Insider Trading

Get notified when an Atossa Therapeutics, Inc. insider buys or sells ATOS shares.

Notify only if

News

Receive news related to ATOSSA THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATOS